Long-term inhibition of ODC1 in APP/PS1 mice rescues amyloid pathology and switches astrocytes from a reactive to active state

Abstract Alzheimer’s disease (AD) is characterized by the loss of memory due to aggregation of misphosphorylated tau and amyloid beta (Aβ) plaques in the brain, elevated release of inhibitory neurotransmitter gamma-aminobutyric acid (GABA) and reactive oxygen species from astrocytes, and subsequent...

Full description

Bibliographic Details
Main Authors: Mridula Bhalla, C. Justin Lee
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Molecular Brain
Subjects:
Online Access:https://doi.org/10.1186/s13041-024-01076-8
_version_ 1797355424362528768
author Mridula Bhalla
C. Justin Lee
author_facet Mridula Bhalla
C. Justin Lee
author_sort Mridula Bhalla
collection DOAJ
description Abstract Alzheimer’s disease (AD) is characterized by the loss of memory due to aggregation of misphosphorylated tau and amyloid beta (Aβ) plaques in the brain, elevated release of inhibitory neurotransmitter gamma-aminobutyric acid (GABA) and reactive oxygen species from astrocytes, and subsequent neurodegeneration. Recently, it was found that enzyme Ornithine Decarboxylase 1 (ODC1) acts as a bridge between the astrocytic urea cycle and the putrescine-to-GABA conversion pathway in the brain of AD mouse models as well as human patients. In this study, we show that the long-term knockdown of astrocytic Odc1 in APP/PS1 animals was sufficient to completely clear Aβ plaques in the hippocampus while simultaneously switching the astrocytes from a detrimental reactive state to a regenerative active state, characterized by proBDNF expression. Our experiments also reveal an effect of astrocytic ODC1 inhibition on the expression of genes involved in synapse pruning and organization, histone modification, apoptotic signaling and protein processing. These genes are previously known to be associated with astrocytic activation and together create a neuroregeneration-supportive environment in the brain. By inhibiting ODC1 for a long period of 3 months in AD mice, we demonstrate that the beneficial amyloid-clearing process of astrocytes can be completely segregated from the systemically harmful astrocytic response to insult. Our study reports an almost complete clearance of Aβ plaques by controlling an endogenous degradation process, which also modifies the astrocytic state to create a regeneration-supportive environment in the brain. These findings present the potential of modulating astrocytic clearance of Aβ as a powerful therapeutic strategy against AD.
first_indexed 2024-03-08T14:10:52Z
format Article
id doaj.art-3e34abea0f374f86ac4ff7b6ca0da375
institution Directory Open Access Journal
issn 1756-6606
language English
last_indexed 2024-03-08T14:10:52Z
publishDate 2024-01-01
publisher BMC
record_format Article
series Molecular Brain
spelling doaj.art-3e34abea0f374f86ac4ff7b6ca0da3752024-01-14T12:42:51ZengBMCMolecular Brain1756-66062024-01-011711910.1186/s13041-024-01076-8Long-term inhibition of ODC1 in APP/PS1 mice rescues amyloid pathology and switches astrocytes from a reactive to active stateMridula Bhalla0C. Justin Lee1Center for Cognition and Sociality, Life Science Institute (LSI), Institute for Basic Science (IBS)Center for Cognition and Sociality, Life Science Institute (LSI), Institute for Basic Science (IBS)Abstract Alzheimer’s disease (AD) is characterized by the loss of memory due to aggregation of misphosphorylated tau and amyloid beta (Aβ) plaques in the brain, elevated release of inhibitory neurotransmitter gamma-aminobutyric acid (GABA) and reactive oxygen species from astrocytes, and subsequent neurodegeneration. Recently, it was found that enzyme Ornithine Decarboxylase 1 (ODC1) acts as a bridge between the astrocytic urea cycle and the putrescine-to-GABA conversion pathway in the brain of AD mouse models as well as human patients. In this study, we show that the long-term knockdown of astrocytic Odc1 in APP/PS1 animals was sufficient to completely clear Aβ plaques in the hippocampus while simultaneously switching the astrocytes from a detrimental reactive state to a regenerative active state, characterized by proBDNF expression. Our experiments also reveal an effect of astrocytic ODC1 inhibition on the expression of genes involved in synapse pruning and organization, histone modification, apoptotic signaling and protein processing. These genes are previously known to be associated with astrocytic activation and together create a neuroregeneration-supportive environment in the brain. By inhibiting ODC1 for a long period of 3 months in AD mice, we demonstrate that the beneficial amyloid-clearing process of astrocytes can be completely segregated from the systemically harmful astrocytic response to insult. Our study reports an almost complete clearance of Aβ plaques by controlling an endogenous degradation process, which also modifies the astrocytic state to create a regeneration-supportive environment in the brain. These findings present the potential of modulating astrocytic clearance of Aβ as a powerful therapeutic strategy against AD.https://doi.org/10.1186/s13041-024-01076-8Alzheimer’s diseaseReactive astrocytesOrnithine decarboxylase 1
spellingShingle Mridula Bhalla
C. Justin Lee
Long-term inhibition of ODC1 in APP/PS1 mice rescues amyloid pathology and switches astrocytes from a reactive to active state
Molecular Brain
Alzheimer’s disease
Reactive astrocytes
Ornithine decarboxylase 1
title Long-term inhibition of ODC1 in APP/PS1 mice rescues amyloid pathology and switches astrocytes from a reactive to active state
title_full Long-term inhibition of ODC1 in APP/PS1 mice rescues amyloid pathology and switches astrocytes from a reactive to active state
title_fullStr Long-term inhibition of ODC1 in APP/PS1 mice rescues amyloid pathology and switches astrocytes from a reactive to active state
title_full_unstemmed Long-term inhibition of ODC1 in APP/PS1 mice rescues amyloid pathology and switches astrocytes from a reactive to active state
title_short Long-term inhibition of ODC1 in APP/PS1 mice rescues amyloid pathology and switches astrocytes from a reactive to active state
title_sort long term inhibition of odc1 in app ps1 mice rescues amyloid pathology and switches astrocytes from a reactive to active state
topic Alzheimer’s disease
Reactive astrocytes
Ornithine decarboxylase 1
url https://doi.org/10.1186/s13041-024-01076-8
work_keys_str_mv AT mridulabhalla longterminhibitionofodc1inappps1micerescuesamyloidpathologyandswitchesastrocytesfromareactivetoactivestate
AT cjustinlee longterminhibitionofodc1inappps1micerescuesamyloidpathologyandswitchesastrocytesfromareactivetoactivestate